Clinical characteristics | n (%) |
---|---|
Total number of patients | 32 |
Male | 15 (46.9%) |
Female | 17 (53.1%) |
Age, years (range) | 59.2 (43–79) |
Nodule size, cm (range) | 0.76 (0.4–1.5) |
Pulmonary function: FEV1, L (range) | 2.15 (1.23–3.56) |
Imaging characteristics of pulmonary nodules | |
Pure ground-glass nodules | 9 (25%) |
Partial solid nodules | 12 (33.3%) |
Solid nodules | 15 (41.7%) |
Nodule location | |
Left upper lobe | 6 (16.7%) |
Left lower lobe | 9 (25%) |
Right upper lobe | 7 (19.4%) |
Right middle lobe | 6 (16.7%) |
Right lower lobe | 8 (22.2%) |
Localization | |
Success | 33 (91.7%) |
Failure | 3 (8.3%) |
Pathology | |
Non-small cell lung cancer | 9 (25%) |
Carcinoma in situ | 5 (13.9%) |
Atypical hyperplasia | 12 (30%) |
Organizing pneumonia | 5 (13.9%) |
Metastatic cancer | 2 (5.6%) |
Lymphoid tissue | 3 (8.3%) |